Voices
Giuseppe Lombardi
Giuseppe Lombardi/pugliaeccellente.info

Giuseppe Lombardi: Targeted Therapies in Optic Pathway Gliomas, a Rare and Clinically Challenging Tumor

Giuseppe Lombardi, Head of the Neuro-Oncology Unit at Veneto Oncology Institute IOV – IRCCS, shared a post on LinkedIn:

“New publication
Happy to share our recently published review on targeted therapies in optic pathway gliomas, a rare and clinically challenging tumor, now out in Cancer Treatment Reviews.

The paper summarizes current evidence and future directions toward precision, biomarker-driven treatment strategies.

A sincere thank you to all co-authors for the great teamwork and for involving me in this multidisciplinary project.”

Title: Targeted therapies in optic pathway gliomas

Authors: Edoardo Agosti, Pier Paolo Panciani, Giuseppe Lombardi, Matthias Preusser, Giorgia De Rosa, Karen Mapelli, Amedeo Piazza, Daniele Tognetto, Caterina Gagliano, Luca Denaro, Marta Padovan, Marco Maria Fontanella, Marco Zeppieri, Tamara Ius

Read the Full Article.

Giuseppe Lombardi: Targeted Therapies in Optic Pathway Gliomas, a Rare and Clinically Challenging Tumor

More posts featuring Giuseppe Lombardi.

Amedeo Piazza cancer Cancer Treatment Reviews Caterina Gagliano Daniele Tognetto Edoardo Agosti Giorgia De Rosa Giuseppe Lombardi Karen Mapelli Luca Denaro Marco Maria Fontanella Marco Zeppieri Marta Padovan Matthias Preusser OncoDaily Oncology Pier Paolo Panciani Tamara Ius